Projects funded by the NCN
Therapeutic activation and signalling determinants of the autoregulatory MBNL1 expression in myotonic dystrophy.
2020/37/B/NZ5/01263
Keywords:
Muscleblind-like 1 (MBNL1) myotonic dystrophy experimental therapy alternative splicing feedback loop signalling pathways transcription factors small activating RNA (saRNA) therapeutic RNA activation (RNAa)
Descriptors:
- NZ5_7: Human disease treatment
- NZ5_3: Pathogenesis of human diseases
- NZ3_7: Signal transduction
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii
woj. wielkopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 6
Call: OPUS 19 - announced on 2020-03-16
Amount awarded: 2 172 624 PLN
Project start date (Y-m-d): 2021-01-22
Project end date (Y-m-d): 2025-01-21
Project duration:: 48 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.